Search

everythinglearnresearchcommunity

for

Search:↓

The procedure accurately measures 5-alpha-dihydrotestosterone in blood, useful for standard tests.

New method effectively detects illegal hormones in anti-aging foods.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

The goal is to create a tool for patients to report their experiences with various hair and scalp disorders.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The mutant HR bmh protein mis-localizes in cells, affecting skin and hair development.

Dr. Rasmussen disagrees with Alexander and Schor, emphasizing uncertainty in genital wart transmission and advocating for discussions on potential abuse and referrals in such cases.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The study aims to create a model to predict health attributes using diverse health data from Japanese adults.

HDMHG0401-10 treatment significantly improved hair count and was better than a placebo in reducing hair loss in men with hereditary hair loss, with no major side effects.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Effective hair loss treatment in men involves personalized care and combination therapies.

High doses of dihydroartemisinin caused reversible liver toxicity in rats, with females more affected than males.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

The term "low-risk" in myelodysplastic syndrome is misleading and should be changed to better reflect patient experiences and needs.

The document gives treatment advice for various skin conditions, like using metronidazole for perioral dermatitis and minoxidil for hair loss.

Self-assessed hirsutism scores are not reliable for clinical diagnosis but may help in screening.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

Methotrexate plus prednisolone had the fewest serious side effects.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Topical minoxidil can cause unwanted hair growth and eye issues, especially in infants, so better education and guidelines are needed.

The method accurately measures Tamsulosin and Finasteride in medication and is suitable for regular quality checks.

Health warnings can increase product sales over time.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.